Advertisement

Topics

JLL Patheon Holdings, LLC Company Profile

12:58 EDT 25th September 2017 | BioPortfolio


News Articles [503 Associated News Articles listed on BioPortfolio]

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Patheon N.V. - PTHN

BALA CYNWYD, PA / ACCESSWIRE / June 23, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Patheon N.V. ("Patheon" or "t...

Thermo Fisher Completes Acquisition of Patheon

Adds Patheon’s leading CDMO capabilities to it portfolio

Thermo Fisher Scientific to acquire Patheon

Thermo Fisher Scientific will acquire Patheon, a global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors. Thermo Fisher will commence a te...

Patheon spends $26m to up capacity for liquid and freeze-dried drugs

Patheon NV has completed a $26m-expansion of its Greenville, North Carolina manufacturing site at which it will make lyophilised pharmaceuticals.

Thermo Fisher announces completion of $7.2B Patheon purchase

Thermo Fisher Scientific finalized the $7.2 billion acquisition of 95.3% in ordinary shares of Patheon, a contract developmen -More- 

Thermo Fisher pulls in funding as it preps for Patheon acquisition

Thermo Fisher Scientific has announced offerings of common stock after extending its tender offer to purchase Patheon.

How Thermo Fisher buying Patheon could simplify pharma supply chains

Thermo Fisher Scientific is set to buy contract manufacturer Patheon, but what would this mean for the life science tech firm?

Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business

Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Case-control study on the use of pituitary-derived hormones from sheep as a potential risk factor for the occurrence of atypical scrapie in Great Britain.

A case-control study was conducted in 2013 to investigate the use of pituitary-derived hormones from sheep as a potential risk factor for the presence of atypical scrapie in Great Britain sheep holdin...

Modelling virus coinfection to inform management of maize lethal necrosis in Kenya.

Maize lethal necrosis (MLN) has emerged as a serious threat to food security in sub-Saharan Africa. MLN is caused by coinfection with two viruses, maize chlorotic mottle virus (MCMV) and a potyvirus, ...

Impact of genetic variation on three dimensional structure and function of proteins.

The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB ar...

Antibiotic drug usage in pigs in Germany-Are the class profiles changing?

The development of antimicrobial resistance is triggered by the use of antibiotic drugs. Therefore, the consumption of antibiotics in livestock is monitored, and different measures may be applied if t...

Discordant detection of avian influenza virus subtypes in time and space between poultry and wild birds; Towards improvement of surveillance programs.

Avian influenza viruses from wild birds can cause outbreaks in poultry, and occasionally infect humans upon exposure to infected poultry. Identification and characterization of viral reservoirs and tr...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Companies [414 Associated Companies listed on BioPortfolio]

Patheon Inc.

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosa...

JLL Patheon Holdings, LLC

Patheon N.V.

Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 9,100 employees and contractors worldwide, Patheon provides a com...

Patheon

Patheon, based in Toronto, Canada, is a leading international provider of pharmaceutical contract manufacturing and development services. Established in 1974, Patheon has grown into a fully integrated...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

More Information about "JLL Patheon Holdings, LLC" on BioPortfolio

We have published hundreds of JLL Patheon Holdings, LLC news stories on BioPortfolio along with dozens of JLL Patheon Holdings, LLC Clinical Trials and PubMed Articles about JLL Patheon Holdings, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of JLL Patheon Holdings, LLC Companies in our database. You can also find out about relevant JLL Patheon Holdings, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record